Literature DB >> 30688629

The clinical significance of carbapenem-resistant Klebsiella pneumoniae rectal colonization in critically ill patients: from colonization to bloodstream infection.

Konstantina Kontopoulou1, Elias Iosifidis2, Eleni Antoniadou3, Polychronis Tasioudis3, Efthymia Petinaki4, Ergina Malli4, Symeon Metallidis5, Alkiviadis Vatopoulos6, Nicolaos Malisiovas7.   

Abstract

PURPOSE: To highlight the clinical significance of carbapenem-resistant Klebsiella pneumoniae (CRKP) rectal colonization by examining the risk factors for CRKP rectal colonization and subsequent bloodstream infection (BSI) in critically ill patients.
METHODOLOGY: Prospective study of CRKP rectal colonization in an intensive care unit (ICU) during a 39-month period. CRKP strains isolated from both the blood cultures and corresponding rectal specimens (n=96) of patients were screened by PCR for the presence of antibiotic resistance-associated genes. Molecular analyses were conducted to investigate the clonal relatedness of CRKP strains from the rectal and blood specimens.
RESULTS: Among the 498 patients, 226 were rectally colonized by CRKP, 48 of whom developed a CRKP BSI. The median time from hospital admission to the detection of CRKP rectal colonization was 8 days, while the median time from colonization to BSI was 4 days. The duration of ICU stay, patient/nurse ratio and prior use of antianaerobic antimicrobials were associated with CRKP rectal colonization. No specific factor was associated with BSIs in the colonized patients. The blaKPC-2 gene was detected in all 96 strains, which were all classified as sequence type ST-258. Representative pairs (n=48) of CRKP strains colonizing and infecting the same patient shared the same pulsotype.
CONCLUSION: Our results indicate that hospitalized patients become infected with their colonizing strains, supporting the strong association between colonization and BSI. Limiting antianaerobic antimicrobial administration, reducing the duration of ICU stay and maintaining a low patient/nurse ratio are possible strategies to restrict rectal CRKP colonization in ICUs.

Entities:  

Keywords:  Carbapenem-resistant Klebsiella pneumoniae; bloodstream infections; colonization; intensive care unit; risk factors

Mesh:

Substances:

Year:  2019        PMID: 30688629     DOI: 10.1099/jmm.0.000921

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  14 in total

1.  Epidemiology and clinical characteristics of infection/colonization due to carbapenemase-producing Enterobacterales in neonatal patients.

Authors:  Jiansheng Wang; Yuanpeng Lv; Weiwei Yang; Peng Zhao; Changfu Yin
Journal:  BMC Microbiol       Date:  2022-07-12       Impact factor: 4.465

2.  Modelling of the transmission dynamics of carbapenem-resistant Klebsiella pneumoniae in hospitals and design of control strategies.

Authors:  Suttikiat Changruenngam; Charin Modchang; Dominique J Bicout
Journal:  Sci Rep       Date:  2022-03-09       Impact factor: 4.996

3.  Comparison of surveillance and clinical cultures to measure the impact of infection control interventions on the incidence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in the hospital.

Authors:  Surbhi Leekha; Lyndsay M O'Hara; Alyssa Sbarra; Shanshan Li; Anthony D Harris
Journal:  Infect Control Hosp Epidemiol       Date:  2020-02       Impact factor: 3.254

4.  Cell envelope defects of different capsule-null mutants in K1 hypervirulent Klebsiella pneumoniae can affect bacterial pathogenesis.

Authors:  Yi Han Tan; Yahua Chen; Wilson H W Chu; Lok-To Sham; Yunn-Hwen Gan
Journal:  Mol Microbiol       Date:  2020-01-20       Impact factor: 3.501

5.  Gastrointestinal Carriage of Vancomycin-Resistant Enterococci and Carbapenem-Resistant Gram-Negative Bacteria in an Endemic Setting: Prevalence, Risk Factors, and Outcomes.

Authors:  Alexandra Vasilakopoulou; Polyxeni Karakosta; Sophia Vourli; Aikaterini Tarpatzi; Paraskevi Varda; Maria Kostoula; Anastasia Antoniadou; Spyros Pournaras
Journal:  Front Public Health       Date:  2020-03-18

6.  Risk factors for carbapenem-resistant Klebsiella pneumoniae infection relative to two types of control patients: a systematic review and meta-analysis.

Authors:  Wei-Min Zhu; Zhe Yuan; Hong-Yu Zhou
Journal:  Antimicrob Resist Infect Control       Date:  2020-01-31       Impact factor: 4.887

7.  The Impact of Modifying Empirical Antibiotic Therapy Based on Intestinal Colonization Status on Clinical Outcomes of Febrile Neutropenic Patients.

Authors:  Ali Alrstom; Tamim Alsuliman; Nizar Daher; Raed Abouharb
Journal:  Infect Chemother       Date:  2021-01-22

8.  Prior Antibiotic Therapy and the Onset of Healthcare-Associated Infections Sustained by Multidrug-Resistant Klebsiella pneumoniae in Intensive Care Unit Patients: A Nested Case-Control Study.

Authors:  Giuseppe Migliara; Valentina Baccolini; Claudia Isonne; Sara Cianfanelli; Carolina Di Paolo; Annamaria Mele; Lorenza Lia; Angelo Nardi; Carla Salerno; Susanna Caminada; Vittoria Cammalleri; Francesco Alessandri; Guglielmo Tellan; Giancarlo Ceccarelli; Mario Venditti; Francesco Pugliese; Carolina Marzuillo; Corrado De Vito; Maria De Giusti; Paolo Villari
Journal:  Antibiotics (Basel)       Date:  2021-03-15

9.  Clinical and Microbiological Characteristics of a Community-Acquired Carbapenem-Resistant Escherichia coli ST410 Isolate Harbouring blaNDM-5-Encoding IncX3-Type Plasmid From Blood.

Authors:  Ji-Na Gu; Lin Chen; Xing-Bei Weng; Xiao-Yan Yang; Dan-Mei Pan
Journal:  Front Med (Lausanne)       Date:  2021-06-11

10.  Bloodstream Infection and Its Clinical Characteristics and Relevant Factors Associated with Interventional Therapy in a Large Tertiary Hospital: A Six Years Surveillance Study.

Authors:  Yanling Bai; Zhigang Zheng; Mingmei Du; Hongwu Yao; Yunxi Liu; Jijiang Suo
Journal:  Biomed Res Int       Date:  2019-10-21       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.